Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection

The outcome of acute hepatitis B virus (HBV) infection is variable, influenced by host and viral factors. From 1982 through 2004, 301 patients with acute HBV infection entered a multi-center cross-sectional study in Japan. Patients with fulminant hepatitis (n = 40) were older (44.7 +/- 16.3 vs. 36.0 +/- 14.3 years, P < .0017), less predominantly mate (43% vs. 71%, P = .0005), less positive for hepatitis B e antigen (HBeAg) (23% vs. 60%, P <.0001), less infected with subgenotype Ae (0% vs. 13%, P <.05), and more frequently with Bj (30% vs. 4%, P <.0001) than those with acute self-limited hepatitis (n = 261). Precore (G1896A) and core-promoter (A1762T/GI764A) mutations were more frequent in patients with fulminant than acute self-limited hepatitis (53% vs. 9% and 50% vs. 17%, P <.0001 for both). HBV infection persisted in only three (1%) patients, and they represented 2 of the 23 infected with Ae and I of the 187 with the other subgenotypes (9% vs. 0.5%, P =.032); none of them received antiviral therapy. In multivariate analysis, age 34 years or older, Bj, HBeAg-negative, total bilirubin 10.0 mg/dL or greater, and G1896A mutation were independently associated with the fulminant outcome. In in vitro transfection experiments, the replication of Bj clone was markedly enhanced by introducing either G1896A or A1762T/GI764A mutation. In conclusion, persistence of HBV was rare (1%) and associated with Ae, whereas fulminant hepatitis was frequent (13%) and associated with Bj and lack of HBeAg as well as high replication due to precore mutation in patients with acute HBV infection.